Semi-synthetic, broad spectrum antibiotic derived from cephamycin C, q.v., possessing high resistance to β-lactamase inactivation. Synthesis: B. G. Christensen et al., DE 2129675; DE 2203653; eidem, US 4297488 (1971, 1972, 1981 all to Merck & Co.); Karady et al., J. Am. Chem. Soc. 94, 1410 (1972); Ratcliffe, Christensen, Tetrahedron Lett. 1973, 4653. Biological evaluation: Wallick, Hendlin, Antimicrob. Agents Chemother. 5, 25 (1974); Miller et al., ibid. 33; Onishi et al., ibid. 38; Hamilton, Miller et al., J. Antibiot. 27, 42 (1974). HPLC determn in serum and tissue: S. K. Cox et al., J. Chromatogr. B 705, 145 (1998). Mode of action: Onishi et al., Ann. N.Y. Acad. Sci. 235, 406 (1974). Toxicity: S. Takayama et al., Chemotherapy (Tokyo) 26, Suppl. 1, 150 (1978). Comprehensive reviews: J. Antimicrob. Chemother. 4, Suppl. B, 1-256 (1978); R. N. Brogden et al., Drugs 17, 1-37 (1979); E. O. Stapley, K. R. Brown, in Pharmacological and Biochemical Properties of Drug Substances vol. 3, M. E. Goldberg, Ed. (Am. Pharm. Assoc., Washington, DC, 1981) pp 262-290. Comprehensive description: G. S. Brenner, Anal. Profiles Drug Subs. 11, 169-195 (1982). Symposium on therapeutic use in anaerobic and aerobic infectons: Hosp. Pract. 25, Suppl. 4, 1-56 (1990).
Antibacterial.
Antibacterial (Antibiotics); β-Lactams; Cephamycins